INTRODUCTION
PrEP is Underutilized by Those Most Likely to Benefit
Pre-exposure prophylaxis (PrEP) for HIV prevention has been available since 2012, but uptake remains both low and inequitable.1–3 In 2022, only 36% of the 1.2 million people with indications for PrEP had received a prescription for it, with profound race, age, gender and geographic disparities in PrEP use.4–6 Black Americans account for 42% of new HIV diagnoses, but only 14% of PrEP users nationwide.2,4,7 In contrast, White Americans represent 26% of new HIV diagnoses, but 64% of PrEP users.7 Americans aged 55 and older are least likely to use PrEP, while women account for only 8% of PrEP users.7 Despite these disparities, most HIV health initiatives have prioritized sexual minority men (SMM: men who do not identify as heterosexual or straight).8–11 Thus, while PrEP is for all, it does not reach all.12
A robust body of research has described scores of individual, clinical, and structural factors that challenge HIV prevention.13–21 This paper focuses on consumer factors, how individuals’ perceptions of PrEP, especially among those most likely to benefit, influence its uptake. By perception, we include awareness, at a minimum knowing that PrEP exists and is available. Awareness may be superficial or detailed and may include accurate and inaccurate beliefs. Research on HIV-related health disparities has noted significant variations in levels of PrEP awareness.10–12 Once people become aware of PrEP, the next step is developing knowledge about PrEP and the opportunity to provide education, to describe its benefits for HIV prevention, and provide information about dosing, administration and potential side effects. Knowledge may generate interest in PrEP, creating an opportunity to address the fit of PrEP to an individual’s needs, a complex set of steps that includes weighing risks and benefits. Finally, if interest is translated into wanting PrEP, strategies to increase PrEP access are imperative to achieve the ultimate goal of enabling PrEP use among those who could benefit.22
Together, these steps comprise demand generation, which “refers to the strategic process of initiating, managing, and increasing consumer interest, desire, and need for a product or service through targeted marketing, advertising, and promotional efforts.”23,24 While awareness interventions aim to increase the accurate information about PrEP, demand-creation efforts aim to increase the desire for PrEP.25,26
Theoretical Approaches to Demand Generation of PrEP
Demand creation interventions use many tools to increase awareness of and demand for PrEP, including social marketing, social and behavior change communication, theories of behavior change, user-centered design, and PRISM RE-AIM, an implementation science framework that considers individual and multi-level factors that impact program outcomes.27–31 More recently, demand-generation strategies have emphasized outcomes that prioritize health equity.32 In our view, PRISM RE-AIM, offers a comprehensive organizing framework for approaches to enhance demand creation strategies. 33 Its components --Determinants, Implementation Strategies, Mechanisms, and Outcomes – readily incorporate approaches such as social marketing, behavior change communication, and user-centered design (Figure 1).
Figure 1:

Determinants, Implementation Strategies, Mechanisms, and Outcomes
The objective of this paper is to describe how consumer perceptions of PrEP differ across population groups, and identify how gaps in PrEP awareness, knowledge and interest – referred to as “demand” in this paper - disproportionately affect populations vulnerable to HIV, including cisgender and transgender women, sexual minority men (SMM) youth, older adults and people who use drugs. Although we will synthesize evidence-based interventions to improve PrEP demand in populations heavily burdened by HIV, evidence on the effectiveness of these interventions for priority populations in the US is limited.34
PrEP Demand in Health Care Settings
The disparities in demand generation can be attributed in part to a lack of interventions that systematically address gaps in awareness and foster sustained interest. Healthcare providers are expected to counsel individuals about PrEP, yet many fail to do so.35,36 Despite the Centers for Disease Control and Prevention (CDC) guidelines recommending that providers discuss PrEP with all sexually active individuals, data suggest that this has not been implemented consistently. For example, Black cisgender women, despite their increased risk for HIV, are rarely told about PrEP by a provider;37 those who are, sometimes report negative experiences.38,39 Similarly, a national survey of over 6,000 cisgender men and transgender persons who have sex with men found that fewer than one-third had discussed PrEP with their healthcare provider.40 Moreover, transgender men often report the lack of provider counseling as a barrier to PrEP use.41
PrEP Demand Among Cisgender and Transgender Women
The HIV epidemic among women in the US remains a critical public health issue, particularly among Black cisgender and transgender women.42 In 2022, 47% of new diagnoses among cisgender women and 62% of new HIV diagnoses among transgender women were among those who were Black.43 However, PrEP uptake is disproportionately low relative to the HIV diagnoses among both populations. Research indicates that about 17% of Black transgender women and fewer than 2% of Black cisgender women who could benefit from PrEP have been prescribed it.44–46 Collectively, these data suggest that there is a large gap in PrEP awareness among Black cisgender women, and underscore a need to strengthen demand creation efforts and improve access to PrEP for both Black cisgender and transgender women.
An important contributor to the suboptimal uptake of PrEP among women is lack of awareness that PrEP is appropriate for them.47–50 Studies with women have shown that many are unaware of or are misinformed about PrEP.43,51–60 For example, among a representative sample of PrEP-eligible, Black cisgender women enrolled in the National HIV Behavioral Surveillance (NHBS) study, only 34.8% were aware of PrEP.6 Although transgender women generally have higher levels of PrEP awareness, they are frequently grouped with SMM in research and messaging which can hinder efforts to develop strategies specifically tailored to their needs.61–63
Pervasive messaging about PrEP fosters the misconception that PrEP is not appropriate for women.53,59,64 This mistaken belief is reinforced by PrEP advertising that predominantly features SMM and lacks images or narratives of women or people of color, signaling that PrEP is not relevant for them.59,64,65 Similarly, Black transgender women indicate that messages that center on white SMM may deter Black transgender women from initiating PrEP.65 However, recent initiatives to reduce HIV incidence are increasingly focused on enhancing PrEP awareness and highlighting its appropriateness for women.66,67
Intervention research to address low awareness among cisgender and transgender women in the US is still nascent. However, individual-level, peer-led interventions, decision-aids, and mobile applications that guide PrEP decision-making have shown promise in increasing PrEP knowledge among women both in the US and globally.40,68 A peer-led intervention in hair salons in the US South significantly improved PrEP knowledge among Black cisgender women, but its impact on PrEP intentions was modest.40 In a study among Black and Latinx cis- and transgender women, 69% reported interest in PrEP after participating in a peer-led intervention, yet none initiated it.59 Another study evaluating a women-focused decision-making tool resulted in a 64% increase in those who were interested in PrEP among cisgender women who used substances; however, none of them actually initiated PrEP.69,70 These data suggest a large gap in PrEP awareness exists among women and highlight the critical need to improve PrEP messaging to increase perceived appropriateness and uptake among both cis- and transgender women.49,50,71
PrEP Demand Among Cisgender and Transgender Men
Awareness and education campaigns about PrEP, often sponsored by federal, state and local governments, public health agencies, and LGBTQ advocacy groups, have targeted their messages to SMM, and these have been quite successful. In 2022, men accounted for 92% of all PrEP prescriptions in the US. However, significant disparities in PrEP uptake persist by race, ethnicity, age and sexual orientation.7 Among SMM participating in the 2021 (NHBS) Study, 89% were aware of PrEP, but only 42% had used it in the prior 12 months.6 Uptake was lower among Black and Native Hawaiian/Other Pacific Islander SMM, as well as those under 25 and over 50 years of age, highlighting disparities even when knowledge is high. Similarly, in a national survey of transgender men conducted between 2017–2018, 91.5% were aware of PrEP, yet only 26.2% reported ever using it. 72 Likewise, in the 2019 NHBS Study, just 29.2% of heterosexual men at higher risk for HIV were aware of PrEP, and only 0.4% had used it.6 Notably, Black heterosexual men accounted for 6% of new HIV infections in 2021, the largest proportion of new HIV infections in the US after SMM and Black women.73 These findings indicate that while PrEP awareness is relatively high, interest and use remain limited.
PrEP Demand Across the Lifespan
In 2021, adolescents and young adults (AYA) aged 13–24 accounted for one-fifth of new HIV diagnoses in the US; 82% were young SMM (YSMM). Among YSMM, Black and Latino individuals accounted for 53% and 34% of new infections, respectively. Despite PrEP being approved for use by AYA in 2018, its uptake remains low.74 In 2022, AYA accounted for only 13% of PrEP users overall, compared to 40% among those aged 25–34.7 Thus, PrEP coverage was only 24% among youth who could benefit from it.12 PrEP awareness and use are particularly low among transgender and non-binary AYA, with only two-thirds aware of PrEP, and just 7% having been prescribed it.75
Minor consent laws for HIV/STI testing and treatment vary by state and significantly affect access to HIV prevention services.76 As of 2021, minors in all 50 states can independently consent to STI and HIV testing and treatment. However, only 32 jurisdictions permit consent for STI prevention services, and 33 jurisdictions77 permit consent for HIV prevention services, including PrEP.77 Some states require clinicians to apply specific criteria before minors can consent, several states lack confidentiality protections for youth, and few states prevent healthcare payors from disclosing services to guardians.78
Older adults also face additional vulnerabilities that influence their use of PrEP, such as increased social isolation, depression, polypharmacy, multiple medical comorbidities, and stigma,79,80 which can hinder PrEP access and uptake. Those age 55 and older accounted for 10% of the new HIV diagnoses in the US, but had the lowest rate of PrEP use81 (46 per 100,000) among any age group in 2022. Psychosocial factors affect access to PrEP and are rarely considered in demand generation initiatives across the lifespan.
PrEP Demand Among Persons Who Use Drugs (PWUD)
In 2019, people who inject drugs (PWID) comprised 3% of the US population but accounted for 7% of new HIV infections.73 Despite this high risk, PrEP is vastly underutilized among this group.82–84 National data from 19 US cities found that while PrEP awareness among PWID increased from 25.6% in 2018 to 35.3% in 2022, use remained at 1.2% in both years.85
The barriers that contribute to low PrEP uptake among PWUD occur across individual, clinical and structural levels.86,87 At the individual-level, PWUD frequently report low self-perceived HIV risk and/or knowledge of PrEP.88 At the clinical-level, the medical system does not provide the infrastructure and capacity for PrEP delivery for a highly mobile population with unique needs such as PWUD,89 while providers themselves have reported less willingness to prescribe PrEP to PWUD than to other populations.20,90 Yet, foremost among these are structural barriers, where housing instability, involvement with the criminal justice system, and lack of financial resources, insurance, identification, or a safe place to store medications complicate the ability to seek care.91
To address these challenges, several strategies have emerged to increase awareness and uptake of PrEP, including the utilization of peer navigators and outreach,92 mobile self-service HIV testing, 93 and partnerships with community-based organizations.94 The latter approach offers several benefits for PrEP delivery by facilitating access to PWUD populations and providing peer support. Pairing PrEP services with syringe service programs95 or organizations that support people experiencing homelessness96 has been shown to increase awareness and uptake. Similarly, integrating PrEP services with medication-assisted treatment for substance use disorders may increase PrEP utilization, as this strategy has been associated with improved outcomes for HIV and HCV treatment.97–102 Finally, the development of long-acting injectable PrEP (LAI-PrEP) is promising, as PWUD express a clear preference for this option over daily oral medication.71,86–88
PrEP Demand Among Those with Intersecting Marginalized Identities
Structural inequalities amplify PrEP-related disparities by limiting health knowledge, and reducing engagement in health-seeking behaviors, including access to HIV prevention services.17,103,104 These inequalities may limit access to information and prescriptions for PrEP, particularly among individuals with multiple intersecting marginalized identities. For example, the Detroit Youth Passages study involving 278 young adults who exchanged sex for money found that unstable housing was a significant predictor of disengagement from healthcare services.105 Limited or poor access to healthcare, a particularly challenging barrier for people experiencing housing instability,106 is pervasive in the US South, and may contribute to the fact that this region has one of the greatest PrEP-to-Need ratios (proportion of PrEP prescriptions compared to number of new HIV diagnoses) compared to other US regions.2,12,107,108
Financial concerns are significant barriers to PrEP use across a number of priority populations.109,110 Misinformation, or a lack of knowledge around co-pays, and the availability of financial support for PrEP (e.g., patient assistance programs) can impede PrEP uptake.111 Media reports of insurers denying coverage to PrEP users contribute toward negative perceptions of PrEP,112,113 and patient concerns regarding insurance107 and ability to pay for PrEP may impact providers’ willingness to prescribe PrEP.114,115 Therefore, ensuring accurate messaging regarding cost, insurance, and availability of financial support for PrEP is essential to increase demand for PrEP.
Medical mistrust exacerbates structural inequities, further hindering use of PrEP by persons with marginalized identities.116–119 For example, Black women report feeling less comfortable talking with healthcare providers about sexual matters than white women, often due to mistrust and negative patient-provider communication patterns.120,121 In addition, Black women have indicated their providers never initiated conversations about PrEP, and they did not bring up PrEP over concern of being judged negatively.38,122,123 Furthermore, this mistrust also poses significant challenges for engaging female sex workers, a group facing multiple layers of marginalized identities, and who often lack trust in a healthcare system that should provide a safe space to learn about and access PrEP.124,125 Therefore, it is imperative that effective policies, procedures, and interventions are put into place to build trust in the medical system and improve providers’ skills to foster open, judgment-free conversations with patients, particularly those most at risk for acquiring HIV,126,127 such as sex workers.
Health care stigma is also a major barrier to acquiring knowledge about and accessing PrEP.17,128–130 “Intersectional stigmas” may influence the type and quality of information providers deliver131 when providers’ biases and discriminatory beliefs affect their PrEP-prescribing behaviors.103,128 Therefore, implementing effective strategies to reduce structural inequalities is essential to increase engagement across the PrEP care continuum for populations burdened by HIV.132 Figure 1 shows drivers of PrEP demand, possible implementation strategies, and mechanisms of action that raise PrEP awareness and increase uptake.
Ramping Up Demand for PrEP
PrEP awareness and equitable use remain low due to both demand-side barriers and accessibility challenges.2 Essential supply-side interventions, such as expanding point-of-care access, must be supplemented with demand-side interventions that raise awareness, dispel misconceptions, provide knowledge and help people determine if PrEP is a good option for them. To date, most such interventions have focused on SMM and consist primarily of online campaigns and use of peer navigators, with scant attention to other priority groups -- women, heterosexual cisgender men, transgender men, people who use drugs, adolescents and older populations.59,133,134 Fortunately, recent efforts to address demand creation among women show some promise135–138 These include the development and evaluation of mobile applications, peer-led interventions, and decision-making tools for both cisgender and transgender women in the US.139,140 Digital communication strategies have been particularly effective with youth.25 A 2021 systematic review highlighted the success of social media campaigns in increasing PrEP awareness and uptake among women and young Black and Latinx SMM in the US.141 Social media also shows promise for reaching transgender men as those using social media for health information were more likely to use PrEP.62,142
PrEP demand generation recognizes that the needs of different groups are not uniform. Tailored approaches should consider specific locations, trusted messengers, and effective messaging to engage priority populations effectively. However, it is unclear what makes strategies effective. Should audience segmentation principles be used to target subgroups with messages most useful for them, or should messaging target diverse populations to avoid stigma?25 For example, a mixed-methods study found that Black SMM considered campaigns featuring predominantly Black SMM to be stigmatizing, whereas diverse couples in advertisements were found to be more engaging and motivating.143 Campaigns can minimize stigma by normalizing PrEP use, building networks of mentors and influencers, reaching communities through targeted advertising, public service announcements, and social media. However, multiple perspectives remain on whether targeted or broader non-targeted campaigns may be most successful.
Healthcare providers can play a critical role in promoting PrEP awareness through initiating PrEP conversations with clients.10,17,18,144 Yet, numerous clinic- and provider-level barriers hinder their ability to discuss and prescribe PrEP, including low provider PrEP knowledge, medical mistrust among clients, and logistics.118 Multifaceted strategies that encompass targeted, inclusive, and non-stigmatizing interventions to educate providers about PrEP, and support them to initiate and manage clients on PrEP are needed.145 Successful examples include public health detailing initiatives from the San Francisco Department of Public Health and the New York City Department of Health and Mental Hygiene, which train clinicians on PrEP implementation and encourage them to prescribe PrEP.146,147
Telehealth is also a promising strategy to facilitate differentiated service delivery by lowering barriers to accessing PrEP, such as transportation, availability of appointments and barriers related to stigma and confidentiality.148,149 Telehealth has been feasible and acceptable by clients and healthcare providers, 150,151 and delivery of services via Telehealth has grown widely.151 Future projects may develop and facilitate strategies to provide Telehealth PrEP for individuals that do not have reliable phone service, as the flexibility of this model offers significant advantages to lower barriers and reach a greater number of individuals in need of PrEP.152,153
Implementation science offers valuable insights into increasing awareness and scaling demand for PrEP by identifying key determinants for success and identifying strategies to minimize burdens on vulnerable groups through streamlined systems. Although research on demand creation strategies and user-centered design for effective PrEP programs is sparse,154 several strategies and tool kits that build PrEP awareness and uptake have emerged, including peer navigation,68 partnerships with community-based organizations,121 and integration of PrEP with syringe service programs95 and organizations serving people experiencing homelessness.148
DESIGNING A PATH FORWARD
Effective interventions to increase PrEP demand involve integrating multiple strategies that address awareness, knowledge, interest/motivation, and access. One strategy is normalizing PrEP, framing universal messages that convey PrEP is for everyone while acknowledging that specific needs and experiences vary across user groups, and avoiding campaigns that unintentionally stigmatize PrEP use. The effectiveness of various strategies in generating demand for PrEP has not yet been fully evaluated. While systematic reviews and meta-analyses exist for evaluating demand creation strategies for SMM,142,155 we were unable to identify similar publications for heterosexual or transgender men in the US.
For women, strategies to increase PrEP knowledge and willingness to use PrEP have been studied across multiple levels. At the clinic or provider-level, interventions such as provider trainings and PrEP clinical decision support tools have been evaluated or are under evaluation for their effectiveness in increasing PrEP awareness among women,156–159 and are effective in increasing individuals’ PrEP knowledge, awareness, and access. However, few studies have specifically focused on providers serving women (e.g., sexual and reproductive healthcare providers, gynecologists, obstetricians) have been evaluated. The limited training programs evaluated for these cadres of healthcare providers have shown great promise and large effects, leading to increased PrEP offerings, referrals, and prescriptions.156,159 At the community-level, social and traditional media campaigns are the primary strategies for raising PrEP awareness among women.
The utilization of implementation science frameworks and theories of behavior change are essential to address both demand generation (interest in PrEP) and supply side barriers to PrEP provision. Yet, demand creation typically has not been integrated as a full partner in PrEP program planning, putting supply side interventions at a disadvantage. Effectively raising awareness about PrEP’s benefits and generating demand could be justified based on behavioral theory and implementation science. Figure 2 details the ways the target population’s characteristics -- such as age, geographic location, and cultural context -- and the product’s attributes interact. Co-creating messages and strategies with users can help craft a coherent narrative that is relevant, appealing, non-stigmatizing and impactful. Incorporating newer PrEP options, such as long-acting injectables, may further expand uptake across diverse multiple populations.61,86,88,160 Additionally, offering PrEP at low or no cost is essential to reducing barriers to access.136
Figure 2:

Action Steps Towards Increasing PrEP Awareness and Demand
Clearly, more research is needed to evaluate the effectiveness of demand-creation strategies, particularly regarding the credibility of message delivery agents, the content of the messages, and the messages are presented to drive demand for PrEP. Ultimately, the goal of all strategies should be to increase PrEP awareness and reduce HIV-related disparities among vulnerable populations: PrEP is for all, but one size does not fit all.
Sources of Support
Dr. McCoy was supported by an Ending the HIV Epidemic Supplement grant to the University of North Carolina at Chapel Hill Center for AIDS Research (P30 AI050410).
Dr. Mantell and Dr. Bauman were supported by an Ending the HIV Epidemic Supplement to the Einstein-Rockefeller-CUNY Center for AIDS Research (3P30 AI124414–08S1).
Dr. Deiss was supported by a grant to the University of California San Diego Center for AIDS Research (P30 AI036214).
Dr. Peasant Bonner was supported by an Ending the HIV Epidemic supplement to the University of North Carolina at Chapel Hill Center for AIDS Research (P30 AI050410).
Footnotes
Conflicts of Interest
Drs. Liu and Buchbinder have institutional grants to their institution from Gilead Sciences, Inc., GlaxoSmith-Kline, Merck, and ViiV Healthcare; and noncash provision of medicines, equipment, or administrative support from Gilead Sciences, Inc. For the remaining authors no conflicts of interest were declared.
Contributor Information
Katryna McCoy, School of Nursing, University of North Carolina at Charlotte, Charlotte, NC.
Joanne E. Mantell, HIV Center for Clinical and Behavioral Studies Columbia University, Department of Psychiatry and the NYS Psychiatric Institute, NY, NY.
Robert Deiss, Division of Infectious Diseases, Department of Medicine, University of California San Diego, San Diego, CA.
Albert Liu, San Francisco Department of Public Health, University of California, San Francisco, San Francisco, CA.
Laurie J. Bauman, Department of Pediatrics & Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY.
Courtney Peasant Bonner, RTI International, Atlanta, GA.
Janie Vinson, Bridge HIV, San Francisco Department of Public Health.
Susan Buchbinder, San Francisco Department of Public Health, University of California, San Francisco, San Francisco, CA.
REFERENCES
- 1.Centers for Disease Control and Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. Aug 10 2012. 1545–861X (Electronic). [PubMed] [Google Scholar]
- 2.Sullivan PS, DuBose SN, Castel AD, et al. Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis. Lancet regional health Americas. 2024;33:100738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Centers for Disease Control and Prevention. Preliminary Data on Pre-Exposure Prophylaxis Coverage 2023; https://www.cdc.gov/hiv/policies/dear-colleague/dcl/20231017.html#print, CDC’s quarterly HIV Surveillance Data Tables. [Google Scholar]
- 5.Odii IO, Vance DE, Patrician PA, et al. HIV PrEP Coverage Among Black Adults: A Concept Analysis of the Inequities, Disparities, and Implications. Health Equity. 2024;8(1):314–324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Baugher AR, Trujillo L, Kanny D, et al. Racial, Ethnic, and Gender Disparities in Awareness of Preexposure Prophylaxis Among HIV-Negative Heterosexually Active Adults at Increased Risk for HIV Infection - 23 Urban Areas, United States, 2019. MMWR Morb Mortal Wkly Rep 2021;70(47):1635–1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sullivan PSWC, Koski C, Pembleton E, McGuinness P, Taussig J, Ricca A, Luisi N, Mokotoff E, Benbow N, Castel AD. AIDSVu. Deeper Look: PrEP 2024; https://aidsvu.org/resources/deeper-look-prep/. [Google Scholar]
- 8.Eisenberg ME, Lawrence SE, Gower AL, et al. Are HIV Prevention Services Reaching all LGBTQ+ Youth? An Intersectional Analysis in a National Sample. AIDS Behav 2024;28(4):1435–1446. [DOI] [PubMed] [Google Scholar]
- 9.Mustanski B, Queiroz A, Merle JL, et al. A Systematic Review of Implementation Research on Determinants and Strategies of Effective HIV Interventions for Men Who Have Sex with Men in the United States. Annu Rev Psychol 2024;75:55–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Andrade EA, Stoukides G, Santoro AF, Karasz A, Arnsten J, Patel VV. Individual and Health System Factors for Uptake of Pre-exposure Prophylaxis Among Young Black and Latino Gay Men. J Gen Intern Med 2023;38(12):2768–2774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.John SA, Zapata JP, Dang M, et al. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old. Sci Rep 2023;13(1):5116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.National Center for HIV VH, STD, and TB Prevention (U.S.). Division of HIV Prevention,. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2023; and Preexposure Prophylaxis (PrEP) Data Reported through March 2023. 2023. [Google Scholar]
- 13.Ezennia O, Geter A, Smith DK. The PrEP Care Continuum and Black Men Who Have Sex with Men: A Scoping Review of Published Data on Awareness, Uptake, Adherence, and Retention in PrEP Care. AIDS Behav 2019;23(10):2654–2673. [DOI] [PubMed] [Google Scholar]
- 14.Threats M, Boyd DT, Diaz JE, Adebayo OW. Deterrents and motivators of HIV testing among young Black men who have sex with men in North Carolina. AIDS Care. 2021;33(7):943–951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gagnon KW, Coulter RWS, Egan JE, Ho K, Hawk M. Facilitators, Barriers, and Opportunities to Implementing Sexual History Screening and Human Immunodeficiency Virus Pre-Exposure Prophylaxis at a Federally Qualified Health Center. AIDS Patient Care STDS 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gómez W, Gomez AM, Solis S, Dimonte C, Organista KC. Provider Perspectives on Multi-level Barriers and Facilitators to PrEP Access Among Latinx Sexual and Gender Minorities. J Racial Ethn Health Disparities. 2024. [DOI] [PubMed] [Google Scholar]
- 17.Seyedroudbari S, Ghadimi F, Grady G, et al. Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review. AIDS Behav 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bruxvoort K, Portugal C, Munis M, Pak K, Hechter R. Understanding Barriers and Facilitators of Pre-exposure Prophylaxis (PrEP) Among Transgender and Gender Diverse Adults in an Integrated Health Care System. AIDS Behav 2023;27(8):2579–2591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dang M, Scheim AI, Teti M, et al. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review. AIDS Patient Care STDS 2022;36(6):236–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pleuhs B, Mistler CB, Quinn KG, et al. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S. Journal of primary care & community health. 2022;13:21501319211063999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.D’Angelo AB, Davis Ewart LN, Koken J, Bimbi D, Brown JT, Grov C. Barriers and Facilitators to Pre-exposure Prophylaxis Uptake Among Black Women: A Qualitative Analysis Guided by a Socioecological Model. J Assoc Nurses AIDS Care. 2021;32(4):481–494. [DOI] [PubMed] [Google Scholar]
- 22.Luca NR, Suggs LS. Theory and model use in social marketing health interventions. Journal of health communication. 2013;18(1):20–40. [DOI] [PubMed] [Google Scholar]
- 23.Strong EK. The psychology of selling and advertising. McGraw-Hill book Company, Incorporated; 1925. [Google Scholar]
- 24.Browning LM. The AIDA Model: A Proven Framework for Converting Strangers Into Customers. 2024; https://blog.hubspot.com/marketing/aida-model. [Google Scholar]
- 25.Sophus AI, Mitchell JW. A Review of Approaches Used to Increase Awareness of Pre-exposure Prophylaxis (PrEP) in the United States. AIDS Behav 2019;23(7):1749–1770. [DOI] [PubMed] [Google Scholar]
- 26.Prevention CfDCa. PrEP Demand Creation Toolkit. 2021; https://www.aidsdatahub.org/resource/prep-demand-generation-toolkit-resource-guide-community-organizations-generate-demand-pre. [Google Scholar]
- 27.Shelton RC, Chambers DA, Glasgow RE. An Extension of RE-AIM to Enhance Sustainability: Addressing Dynamic Context and Promoting Health Equity Over Time. Frontiers in public health. 2020;8:134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Glasgow RE, Harden SM, Gaglio B, et al. RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review. Frontiers in public health. 2019;7:64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chambers DA, Glasgow RE, Stange KC. The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implementation science : IS 2013;8:117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nilsen P, Bernhardsson S. Context matters in implementation science: a scoping review of determinant frameworks that describe contextual determinants for implementation outcomes. BMC health services research. 2019;19(1):189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Fort MP, Manson SM, Glasgow RE. Applying an equity lens to assess context and implementation in public health and health services research and practice using the PRISM framework. Frontiers in health services. 2023;3:1139788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kwan BM, McGinnes HL, Ory MG, Estabrooks PA, Waxmonsky JA, Glasgow RE. RE-AIM in the Real World: Use of the RE-AIM Framework for Program Planning and Evaluation in Clinical and Community Settings. Front Public Health. 2019;7:345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wang Y, Mitchell JW, Zhang C, Liu Y. Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systematic review. AIDS Res Ther 2022;19(1):28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Isehunwa OO, Hill SV, Menninger AT, et al. A Multicomponent Intervention to Train and Support Family Medicine Providers to Promote Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in the Deep South: Protocol for the PrEP-Pro Study. JMIR Res Protoc 2023;12:e44908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Martinez-Cajas JL, Torres J, Mueses HF, et al. Applying implementation science frameworks to identify factors that influence the intention of healthcare providers to offer PrEP care and advocate for PrEP in HIV clinics in Colombia: a cross-sectional study. Implementation science communications. 2022;3(1):31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Jackson KJ, Chitle P, McCoy SI, White DAE. A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care. J Community Health. 2024;49(3):499–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Knight D, Saleem HT, Stockman JK, Willie TC. Experiences of Black Women in the United States Along the PrEP Care Continuum: A Scoping Review. AIDS Behav 2023;27(7):2298–2316. [DOI] [PubMed] [Google Scholar]
- 39.Dauria EF, Levine A, Hill SV, Tolou-Shams M, Christopoulos K. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women. Arch Sex Behav 2021;50(4):1743–1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Randolph SD, Johnson R, Jeter E, McGee K, Johnson A. UPDOs Protective Styles, a Multilevel Intervention to Improve Pre-exposure Prophylaxis Uptake Among Black Cisgender Women: Pretest-Posttest Evaluation. J Assoc Nurses AIDS Care. 2023;34(5):459–468. [DOI] [PubMed] [Google Scholar]
- 41.Rowniak S, Ong-Flaherty C, Selix N, Kowell N. Attitudes, Beliefs, and Barriers to PrEP Among Trans Men. AIDS Educ Prev 2017;29(4):302–314. [DOI] [PubMed] [Google Scholar]
- 42.Sullivan PS, Satcher Johnson A, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397(10279):1095–1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Patel AS, Goparaju L, Sales JM, et al. Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019;80(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Conley C, Johnson R, Bond K, Brem S, Salas J, Randolph S. US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review. Womens Health (Lond). 2022;18:17455057221103098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States. J Acquir Immune Defic Syndr 2020;84(5):437–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Poteat T, Wirtz A, Malik M, et al. A Gap Between Willingness and Uptake: Findings From Mixed Methods Research on HIV Prevention Among Black and Latina Transgender Women. J Acquir Immune Defic Syndr 2019;82(2):131–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Nogueira NF, Luisi N, Salazar AS, et al. PrEP awareness and use among reproductive age women in Miami, Florida. PLoS One. 2023;18(6):e0286071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Haider S, Friedman EE, Ott E, et al. Knowledgeable, aware / interested: Young black women’s perceptions of pre-exposure prophylaxis. Frontiers in reproductive health. 2022;4:671009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wilson EC, Turner CM, Arayasirikul S, et al. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies. J Int AIDS Soc 2020;23 Suppl 3(Suppl 3):e25539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city. AIDS Care. 2018;30(1):9–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Browne FABC, van der Drift I, Smith K, Wechsberg WM A Cross-Sectional Assessment of PrEP Awareness and Readiness among Young Black Women in Emerging Adulthood in North Carolina. In. [Google Scholar]
- 52.Carley T, Siewert E, Naresh A. Interest in Pre-exposure Prophylaxis (PrEP) for HIV is Limited Among Women in a General Obstetrics & Gynecology Setting. AIDS Behav 2019;23(10):2741–2748. [DOI] [PubMed] [Google Scholar]
- 53.Chandler R, Guillaume D, Wells J, Hernandez N. Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option. Int J Environ Res Public Health. 2022;19(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hill LM, Lightfoot AF, Riggins L, Golin CE. Awareness of and attitudes toward pre-exposure prophylaxis among African American women living in low-income neighborhoods in a Southeastern city. AIDS Care. 2021;33(2):239–243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hirschhorn LR, Brown RN, Friedman EE, et al. Black Cisgender Women’s PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago. J Acquir Immune Defic Syndr 2020;84(5):497–507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Pasipanodya EC, Stockman J, Phuntsog T, et al. “PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women. BMC Womens Health. 2021;21(1):220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Raifman JR, Schwartz SR, Sosnowy CD, et al. Brief Report: Pre-exposure Prophylaxis Awareness and Use Among Cisgender Women at a Sexually Transmitted Disease Clinic. J Acquir Immune Defic Syndr 2019;80(1):36–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Whitehead S PrEP prevents HIV infections, but it’s not reaching Black women. In. National Public Radio 2023. [Google Scholar]
- 59.Willie TC, Knight D, Baral SD, et al. Where’s the “Everyday Black Woman”? An intersectional qualitative analysis of Black Women’s decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi. BMC Public Health. 2022;22(1):1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Collier KL, Colarossi LG, Sanders K. Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives. J Health Commun 2017;22(3):183–189. [DOI] [PubMed] [Google Scholar]
- 61.Weeden T, Garofalo R, Johnson AK, et al. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women. Academic pediatrics. 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Reisner SL, Moore CS, Asquith A, Pardee DJ, Mayer KH. The Pre-Exposure Prophylaxis Cascade in At-Risk Transgender Men Who Have Sex with Men in the United States. LGBT Health. 2021;8(2):116–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Matos LA, Janek SE, Holt L, Ledbetter L, Gonzalez-Guarda RM. Barriers and Facilitators Along the PrEP Continuum of Care Among Latinx Sexual Minoritized Men and Transgender Women: A Systematic Review. AIDS Behav 2024. [DOI] [PubMed] [Google Scholar]
- 64.Bonner CPC, E., Hairston I, Smith A, Howard BN, Browne FA, Roberts ST, Hull KJ, Dixon, Diall D, Wechsberg WM,. Centering the Diverse Voices of Black Women to Understand PrEP Awareness and Access in the South. Perspectives on Sexual and Reproductive Health. In. [Google Scholar]
- 65.Nieto O, Fehrenbacher AE, Cabral A, Landrian A, Brooks RA. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users. AIDS Care. 2021;33(2):244–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Richmond T, Dunn M, Bernard M, et al. 1550. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women. Open Forum Infectious Diseases. 2023;10(Supplement_2). [Google Scholar]
- 67.Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: A Plan for the United States. JAMA 2019;321(9):844–845. [DOI] [PubMed] [Google Scholar]
- 68.Blackstock OJ, Platt J, Golub SA, et al. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS Behav 2021;25(5):1411–1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Meyer J, Price C, Tracey D, et al. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders. Patient Prefer Adherence. 2021;15:1913–1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Waldron EM, Goodman GR, Rivas AM, et al. Perceptions of and preferences for PrEP use among African American women and providers in the U.S. South: a qualitative study. Psychol Health. 2024:1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Zamantakis A, Li DH, Benbow N, Smith JD, Mustanski B. Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review. AIDS Behav 2023;27(5):1600–1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Zarwell M, John SA, Westmoreland D, et al. PrEP Uptake and Discontinuation Among a U.S. National Sample of Transgender Men and Women. AIDS Behav 2021;25(4):1063–1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2018–2022. HIV Surveillance Supplemental Report. 2024;29(1). [Google Scholar]
- 74.Camfield C, Evans YN, Kumbhakar RG. HIV preexposure prophylaxis in adolescents and young adults: an update. Curr Opin Pediatr 2024. [DOI] [PubMed] [Google Scholar]
- 75.Rodriguez A, Horvath KJ, Dowshen N, et al. Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults. Frontiers in reproductive health. 2023;5:1150370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Culp L, Caucci L. State adolescent consent laws and implications for HIV pre-exposure prophylaxis. Am J Prev Med 2013;44(1 Suppl 2):S119–124. [DOI] [PubMed] [Google Scholar]
- 77.Nelson KM, Skinner A, Stout CD, et al. Minor Consent Laws for Sexually Transmitted Infection and Human Immunodeficiency Virus Services in the United States: A Comprehensive, Longitudinal Survey of US State Laws. Am J Public Health. 2023;113(4):397–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Nelson KM, Skinner A, Underhill K. Minor Consent Laws for Sexually Transmitted Infection and HIV Services. Jama 2022;328(7):674–676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Brown MJ, Adeagbo O. HIV and Aging: Double Stigma. Current epidemiology reports. 2021;8(2):72–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Mbalinda SN, Lusota DA, Muddu M, Nyashanu M. Ageing with HIV: challenges and coping mechanisms of older adults 50 years and above living with HIV in Uganda. BMC Geriatr 2024;24(1):95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Center for Disease Control and Prevention. HIV Surveillance Report: Diagnoses of HIV Infection in the United States and Dependent Areas, 2021. 2023; https://stacks.cdc.gov/view/cdc/149071. [Google Scholar]
- 82.Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The Past, Present, and Future of PrEP implementation Among People Who Use Drugs. Curr HIV/AIDS Rep 2021;18(4):328–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Picard J, Jacka B, Høj S, et al. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs. AIDS Behav 2020;24(8):2400–2408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Qin Y, Price C, Rutledge R, Puglisi L, Madden LM, Meyer JP. Women’s Decision-Making about PrEP for HIV Prevention in Drug Treatment Contexts. J Int Assoc Provid AIDS Care. 2020;19:2325958219900091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Chapin-Bardales D, Broz D, Eustaquio P, Feelemyer J, Finlayson T, Harris S, & Wejnert C,. Changes in HIV PrEP Awareness and Use Among PWID in 19 US Cities, 2018 and 2022. Conference on Retroviruses and Opportunistic Infections (CROI); 2024, March 3–6, 2024; Denver, Colorado, United States. [Google Scholar]
- 86.Allen ST, O’Rourke A, White RH, et al. Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study. AIDS Behav 2020;24(6):1942–1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Biello KB, Bazzi AR, Mimiaga MJ, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J 2018;15(1):55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Bazzi ARVC, Streuli SA, Vera CF, Harvey-Vera A, Philbin MM, Biello KB, Roth AM, Strathdee SA, Pines HA. Long-acting injectable HIV pre-exposure prophylaxis preferred over other modalities among people who inject drugs: findings from a qualitative study in California. . AIDS Patient Care & STDs 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Jaiswal J, Griffin M, Hascher K, et al. Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives. J Addict Med 2022;16(5):e278–e283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Edelman EJ, Moore BA, Calabrese SK, et al. Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs. AIDS and Behavior. 2017;21(4):1025–1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Shaw G, Schaefer R, Schmidt HA, et al. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery. Harm Reduct J 2023;20(1):16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Blackstock OJ, Platt J, Golub SA, et al. A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection. AIDS and Behavior. 2021;25(5):1411–1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Bazzi AR, Valasek CJ, Stamos-Buesig T, et al. Health, harm reduction, and social service providers’ perspectives on the appropriateness and feasibility of peer distribution of HIV self-test kits among people who use drugs. Harm Reduction Journal. 2024;21(1):29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Mayer KH, Chan PA, Patel R, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States. Journal of acquired immune deficiency syndromes (1999). 2018;77(2):119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Roth AM, Tran NK, Felsher M, et al. Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study. J Acquir Immune Defic Syndr 2021;86(3):e61–e70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. New England Journal of Medicine. 2021;385(7):595–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Bamford L, Benitez J, Muñoz-Laboy M. Providing HIV Comprehensive Care to Latino/as Who Inject Drugs: Philadelphia, 2013–2018. American journal of public health. 2019;109(2):273–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Jin H, Ogunbajo A, Mimiaga MJ, et al. Over the influence: the HIV care continuum among methamphetamine-using men who have sex with men. Drug and alcohol dependence. 2018;192:125–128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. Bmj 2012;345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Platt L, Minozzi S, Reed J, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113(3):545–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Simeone C, Shapiro B, Lum PJ. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic. Addiction science & clinical practice. 2017;12(1):1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PloS one. 2012;7(5):e38335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Advances in therapy. 2020;37(5):1778–1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Calabrese SK, Kalwicz DA, Modrakovic D, et al. An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers’ PrEP-Related Clinical Judgments. AIDS and Behavior. 2022;26(5):1393–1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Knittel AK, Graham LF, Peterson J, Lopez W, Snow RC. Access to Health Care Services among Young People Exchanging Sex in Detroit. Journal of Urban Health. 2019;96(3):452–468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Blackstock OJ, Frew P, Bota D, et al. Perceptions of Community HIV/STI Risk Among U.S Women Living in Areas with High Poverty and HIV Prevalence Rates. J Health Care Poor Underserved. 2015;26(3):811–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Terlizzi EP, Cohen RA. Geographic Variation in Health Insurance Coverage:United States, 2022. National health statistics reports. 2023(194):1–15. [PubMed] [Google Scholar]
- 108.Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Annals of epidemiology. 2018;28(12):841–849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Wood SM, Bauermeister J, Fiks AG, et al. Adolescent Preferences for a Pediatric Primary Care-based Sexually Transmitted Infection and HIV Prevention Intervention. J Adolesc Health. 2024;74(6):1231–1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Advances in therapy. 2020;37(5):1778–1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers’ Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care. PLoS One. 2016;11(6):e0157324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Kolata G Facing legal action, insurer now will cover people taking Truvada, an H.I.V.-prevention drug. 2019; https://www.nytimes.com/2019/01/10/health/hiv-aids-truvada-insurance.html. [Google Scholar]
- 113.A Urologist, PrEP, and Discriminatory Disability Insurance Practices: Dr. Paul Sax Interviews Dr. Philip Cheng. Open Forum Infect Dis 2018;5(6):ofy149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(5):704–712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Wood BR, McMahan VM, Naismith K, Stockton JB, Delaney LA, Stekler JD. Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers. Sex Transm Dis 2018;45(7):452–458. [DOI] [PubMed] [Google Scholar]
- 116.Irie WC, Mahone A, Johnson B, et al. “Just the Stigma Associated with PrEP Makes You Feel Like It’s HIV Itself”: Exploring PrEP Stigma, Skepticism, and Medical Mistrust Among Black Cisgender Women in Urban and Rural Counties in the U.S. Deep South. Arch Sex Behav 2024;53(3):1187–1195. [DOI] [PubMed] [Google Scholar]
- 117.Heads AM, Hill MJ, Suchting R, Yammine L, Gilmore-Thomas A. Predictors of Anticipated PrEP Stigma among Women with Self-Reported Problematic Substance Use: Implications for Engaging Women in the PrEP Care Continuum. Arch Sex Behav 2021;50(7):2955–2964. [DOI] [PubMed] [Google Scholar]
- 118.Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, Mayer KH. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2017;29(11):1351–1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Wiginton JM, Eaton LA, Watson RJ, Maksut JL, Earnshaw VA, Berman M. Sex-Positivity, Medical Mistrust, and PrEP Conspiracy Beliefs Among HIV-Negative Cisgender Black Sexual Minority Men in Atlanta, Georgia. Arch Sex Behav 2022;51(5):2571–2581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Tekeste M, Hull S, Dovidio JF, et al. Differences in Medical Mistrust Between Black and White Women: Implications for Patient-Provider Communication About PrEP. AIDS Behav 2019;23(7):1737–1748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Üsküp DK, Nieto O, Rosenberg-Carlson E, Brooks RA. Acceptability and appropriateness of information sessions to increase knowledge and awareness of PrEP and TelePrEP among Latina Women. AIDS Care. 2024;36(8):1162–1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.McCoy K Enhancing Strategies To Engage Providers in Efforts to Eliminate HIV: The Project EnSTEP Protocol. In. [Google Scholar]
- 123.Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res 2017;8(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Singer RB, Barrow J, Johnson AK, et al. Centering PrEP: utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago. BMC Public Health. 2024;24(1):56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Paz-Bailey G, Noble M, Salo K, Tregear SJ. Prevalence of HIV Among U.S. Female Sex Workers: Systematic Review and Meta-analysis. AIDS Behav 2016;20(10):2318–2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.King H, Thornton N, Evans KN, et al. Factors Associated with the Awareness of and Willingness to Use HIV Pre-exposure Prophylaxis Among Gay, Bisexual, and Other Men Who Have Sex with Men, Baltimore, MD, 2017–2019. J Racial Ethn Health Disparities. 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Sewell WC, Blankenship SA. Perceived HIV risk as a predictor of sexual risk behaviors and discrimination among high-risk women. AIDS Care. 2019;31(6):675–680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Hull SJ, Tessema H, Thuku J, Scott RK. Providers PrEP: Identifying Primary Health care Providers’ Biases as Barriers to Provision of Equitable PrEP Services. J Acquir Immune Defic Syndr 2021;88(2):165–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Farley JE, Beuchamp G, Bergman A, et al. The Impact of Stigma and Sexual Identity on PrEP Awareness and Use Among At-Risk Men Who Have Sex With Men in Four U.S. Cities (HPTN 078). Stigma Health. 2024;9(3):400–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Mustanski B, Ryan DT, Hayford C, Phillips G, Newcomb ME, Smith JD. Geographic and Individual Associations with PrEP Stigma: Results from the RADAR Cohort of Diverse Young Men Who have Sex with Men and Transgender Women. AIDS and Behavior. 2018;22(9):3044–3056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Knittel AK, Ferguson EG, Jackson JB, Adimora AA. The influence of social relationships on PrEP attitudes among women with incarceration experience in the Southeastern USA. Cult Health Sex. 2023;25(1):110–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia. Clinical Infectious Diseases. 2015;61(10):1590–1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Knight D, Saleem HT, Stockman JK, Willie TC. Experiences of Black Women in the United States Along the PrEP Care Continuum: A Scoping Review. AIDS and Behavior. 2023;27(7):2298–2316. [DOI] [PubMed] [Google Scholar]
- 134.Bradley E, Forsberg K, Betts JE, et al. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review. J Womens Health (Larchmt). 2019;28(9):1272–1285. [DOI] [PubMed] [Google Scholar]
- 135.ViiV Healthcare. From risks to reasons: A guide for communicating and connecting with Black women about HIV. 2022; https://viivhealthcare.com/content/dam/cf-viiv/viivhealthcare/en_US/pdf/from-risk-to-reasons-reframing-hiv-prevention-and-care-for-black-women-spreads.pdf. [Google Scholar]
- 136.Johnson R, Conley C, Jeter E, Randolph SD. PrEP-aring stylists: Development of a stylist educational workshop to increase PrEP awareness and knowledge among Black women in the US south Public Health Nurs 2024;41(1):57–66. [DOI] [PubMed] [Google Scholar]
- 137.Izadi LH, Mmeje O, Drabo EF, Perin J, Martin S, Coleman JS. An effectiveness-implementation trial protocol to evaluate PrEP initiation among U.S. cisgender women using eHealth tools vs. standard care. Frontiers in reproductive health. 2023;5:1196392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Dauria E, Rodriguez C, Bauerle Bass S, Tolou-Shams M, Christopoulos K. Implementation strategies to screen, refer and link women involved in the carceral system to PrEP for HIV prevention. Int J Prison Health. 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Wechsberg WM, Browne FA, Ndirangu J, et al. The PrEPARE Pretoria Project: protocol for a cluster-randomized factorial-design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa. BMC Public Health. 2020;20(1):1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Chandler R, Farinu OTO, Guillaume D, et al. Digital Health App to Address Disparate HIV Outcomes Among Black Women Living in Metro-Atlanta: Protocol for a Multiphase, Mixed Methods Pilot Feasibility Study. JMIR Res Protoc 2023;12:e42712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Kudrati SZ, Hayashi K, Taggart T. Social Media & PrEP: A Systematic Review of Social Media Campaigns to Increase PrEP Awareness & Uptake Among Young Black and Latinx MSM and Women. AIDS Behav 2021;25(12):4225–4234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Walsh-Buhi E, Houghton RF, Lange C, Hockensmith R, Ferrand J, Martinez L. Pre-exposure Prophylaxis (PrEP) Information on Instagram: Content Analysis. JMIR Public Health Surveill. 2021;7(7):e23876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Calabrese SK, Kalwicz DA, Dovidio JF, et al. Targeted social marketing of PrEP and the stigmatization of black sexual minority men. PLoS One. 2023;18(5):e0285329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Irie WC, Croston MA, Mahone A. The Impact of Providers as Health Discussants on Black Women’s Interest in PrEP for HIV Prevention. J Int Assoc Provid AIDS Care. 2024;23:23259582231225278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation Strategies to Increase PrEP Uptake in the South. Curr HIV/AIDS Rep 2019;16(4):259–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Stojanovski K, Decker A, Brosnan H, et al. Public Health Detailing on Sexual Health Care in San Francisco: Learnings From Real-World Implementation. Public Health Rep 2023;138(2):232–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Wahnich A, Gandhi AD, Cleghorn E, et al. Public Health Detailing to Promote HIV Pre- and Postexposure Prophylaxis Among Women’s Healthcare Providers in New York City. Am J Prev Med 2021;61(5 Suppl 1):S98–s107. [DOI] [PubMed] [Google Scholar]
- 148.Biello KB, Bazzi AR, Vahey S, Harris M, Shaw L, Brody J. Delivering Preexposure Prophylaxis to People Who Use Drugs and Experience Homelessness, Boston, MA, 2018–2020. Am J Public Health. 2021;111(6):1045–1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Giorlando KK, Arnold T, Barnett AP, et al. Acceptability and comfort regarding remotely delivered PrEP services in Mississippi. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2023;22:23259582231186868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Barnett AP, Arnold T, Elwy AR, et al. Considerations for PrEP Implementation at Federally Qualified Health Centers in Mississippi: Perspectives From Staff and Patients. AIDS Educ Prev 2023;35(4):309–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Bonett S, Li Q, Sweeney A, Gaither-Hardy D, Safa H. Telehealth Models for PrEP Delivery: A Systematic Review of Acceptability, Implementation, and Impact on the PrEP Care Continuum in the United States. AIDS and Behavior. 2024;28(9):2875–2886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Rutstein SE, Muessig KE. Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States. Curr HIV/AIDS Rep 2024;21(2):52–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Bonett S, Li Q, Sweeney A, Gaither-Hardy D, Safa H. Telehealth Models for PrEP Delivery: A Systematic Review of Acceptability, Implementation, and Impact on the PrEP Care Continuum in the United States. AIDS Behav 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Bass E, Fitch L, Gomez A, Loar R. Demand creation for primary biomedical prevention: identifying lessons across interventions to inform daily oral preexposure prophylaxis programs. Curr Opin HIV AIDS 2019;14(1):28–40. [DOI] [PubMed] [Google Scholar]
- 155.Irie WC, Calabrese SK, Mayer KH, Geng EH, Blackstock O, Marcus JL. Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States. AIDS Care. 2024;36(5):672–681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Casey E, Kaplan-Lewis E, Gala K, Lakew R. Successful Integration of HIV PrEP in Primary Care and Women’s Health Clinical Practice: A Model for Implementation. Viruses. 2023;15(6). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Richmond T, Dunn M, Bernard M, et al. Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women. Open Forum Infectious Diseases. 2023;10(Supplement_2). [Google Scholar]
- 158.Valenti WM, Phoenix J, Patel RR, et al. Integrating Long-acting Injectable Cabotegravir for PrEP into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex with Men: Results from the PILLAR & EBONI Studies. Open Forum Infectious Diseases. 2023;10(Supplement_2). [Google Scholar]
- 159.Sales JM, Cwiak C, Haddad LB, et al. Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia. J Acquir Immune Defic Syndr 2019;81(4):414–418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Shrestha R, DiDomizio EE, Kim RS, Altice FL, Wickersham JA, Copenhaver MM. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. Journal of substance abuse treatment. 2020;117:108058. [DOI] [PMC free article] [PubMed] [Google Scholar]
